Satellos Bioscience (MSLE) Current Assets (2023 - 2026)

Satellos Bioscience (MSLE) has 4 years of Current Assets data on file, last reported at $75.2 million in Q1 2026.

• On a quarterly basis, Current Assets changed N/A year-over-year to $75.2 million in Q1 2026; TTM through Mar 2026 was $75.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $31.9 million, down 37.17% from the prior year.
• Current Assets for Q1 2026 stood at $75.2 million, up from $31.9 million in the prior quarter.
• Over the last five years, Current Assets for MSLE reached as high as $75.2 million in Q1 2026 and fell as low as $29.6 million in Q4 2023.
• Historically, Current Assets has averaged $47.2 million across 4 years, with a median of $42.1 million in 2024.
• Across the five-year window, Current Assets jumped 76.47% in 2024 and tumbled 39.0% in 2025, its largest moves.
• Year by year, Current Assets stood at $29.6 million in 2023, then soared by 76.47% to $52.3 million in 2024, then sank by 39.0% to $31.9 million in 2025, then soared by 135.91% to $75.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $75.2 million in Q1 2026, $31.9 million in Q4 2025, and $52.3 million in Q4 2024.